VeriMom¿Es valprooyl oligopeptide-33 seguro durante el embarazo?
I could not find authoritative safety or classification data for an ingredient named 'valprooyl oligopeptide-33' in the major cosmetic/regulatory sources. No harmonised CLP classification, SCCS opinion, or CIR assessment for this exact name is available in my training knowledge; therefore default scoring is 0. If this ingredient is an acylated peptide containing a valproyl (valproic acid–derived) group, that parent (valproic acid / sodium valproate) is a known teratogen, but I have no confirmed evidence that this specific cosmetic ingredient is that derivative or that it releases valproic acid in vivo.
Related ingredients
Frequently asked questions
- ¿Es valprooyl oligopeptide-33 seguro durante el embarazo?
- I could not find authoritative safety or classification data for an ingredient named 'valprooyl oligopeptide-33' in the major cosmetic/regulatory sources. No harmonised CLP classification, SCCS opinion, or CIR assessment for this exact name is available in my training knowledge; therefore default scoring is 0. If this ingredient is an acylated peptide containing a valproyl (valproic acid–derived) group, that parent (valproic acid / sodium valproate) is a known teratogen, but I have no confirmed evidence that this specific cosmetic ingredient is that derivative or that it releases valproic acid in vivo.
- ¿Es valprooyl oligopeptide-33 seguro durante la lactancia?
- No data located in the referenced authoritative sources for breastfeeding-specific effects of 'valprooyl oligopeptide-33'. In absence of documented systemic absorption or reproductive/breastfeeding data, default hazard/exposure scores remain 0. If the ingredient were to liberate valproic acid systemically, breastfeeding concerns would follow those for valproate, but that linkage is not established here.
- ¿Es valprooyl oligopeptide-33 seguro para la piel del bebé?
- No specific data for infants (0–3 yr) were found. By default there is no evidence of hazard or mechanism for this ingredient. Because infant skin has higher absorption potential for ingredients that are measurably absorbed in adults, I assign a conservative exposure increase of +1 only if the ingredient has any measurable dermal absorption; however, no data confirming adult absorption were located for this specific ingredient.
- ¿Cómo puntúa VeriMom a valprooyl oligopeptide-33?
- VeriMom puntúa valprooyl oligopeptide-33 en 100/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a valprooyl oligopeptide-33 en el embarazo?
- Consulta nuestra lista de alternativas seguras a valprooyl oligopeptide-33 según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.